Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pollard

Showing results (211-220 of 216) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 216 results.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Annals of Internal Medicine|March 1, 1994
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study GroupS L Spruance, A T Pavia, D Peterson, et al.
Neurology|February 10, 2015
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsyVicenta Salanova, Thomas Witt, Robert Worth, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifsSavvas Kleanthous, Alan D Borthwick, David Brown, et al.
Nature|January 13, 2012
One or more bound planets per Milky Way star from microlensing observationsA Cassan, D Kubas, J-P Beaulieu, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 22

Showing results (211-220 of 216) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 216 results.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Annals of Internal Medicine|March 1, 1994
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study GroupS L Spruance, A T Pavia, D Peterson, et al.
Neurology|February 10, 2015
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsyVicenta Salanova, Thomas Witt, Robert Worth, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifsSavvas Kleanthous, Alan D Borthwick, David Brown, et al.
Nature|January 13, 2012
One or more bound planets per Milky Way star from microlensing observationsA Cassan, D Kubas, J-P Beaulieu, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 22